VivoSim Labs (VIVS) Enterprise Value (2010 - 2026)
VivoSim Labs (VIVS) posted quarterly Enterprise Value of -$5.0 million for Q1 2026, up 55.59% year-over-year from -$3.2 million in Q1 2025, and down 17.16% quarter-over-quarter from -$4.3 million in Q4 2025.
VivoSim Labs (VIVS) Enterprise Value (2010 - 2026) Analysis & Trends
VivoSim Labs' Enterprise Value history runs 17 years deep, the most recent figure standing at -$5.0 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 55.59% year-over-year to -$5.0 million; the TTM figure through Mar 2026 stood at -$5.0 million (up 55.59% YoY), while the FY2026 annual figure was -$5.0 million, up 55.59% from the prior year.
- Enterprise Value for Q1 2026 stood at -$5.0 million, down from -$4.3 million in the prior quarter.
- The five-year high for Enterprise Value was -$1.2 million in Q4 2024, with the low at -$28.7 million in Q1 2022.
- The 5-year median for Enterprise Value is -$7.6 million (2023), against an average of -$11.0 million.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 81.04% in 2024, then tumbled 289.93% in 2025.
- VivoSim Labs' Enterprise Value stood at -$20.2 million in 2022, then jumped by 73.78% to -$5.3 million in 2023, then surged by 78.07% to -$1.2 million in 2024, then plunged by 269.34% to -$4.3 million in 2025, then dropped by 17.16% to -$5.0 million in 2026.
- Business Quant data shows VIVS's Enterprise Value at -$5.0 million in Q1 2026, -$4.3 million in Q4 2025, and -$6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 2.12 Bn |
| 10 | VivoSim Labs | 1.44 Mn | 1.44 Mn | - | -1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.70 Mn |
| Mar 31, 2026 | -5.02 Mn |
| Dec 31, 2025 | -4.29 Mn |
| Sep 30, 2025 | -6.70 Mn |
| Jun 30, 2025 | -9.06 Mn |
| Mar 31, 2025 | -11.31 Mn |
| Dec 31, 2024 | -1.16 Mn |
| Sep 30, 2024 | -3.17 Mn |
| Jun 30, 2024 | -6.19 Mn |
| Mar 31, 2024 | -2.90 Mn |
| Dec 31, 2023 | -5.30 Mn |
| Sep 30, 2023 | -7.62 Mn |
| Jun 30, 2023 | -10.75 Mn |
| Mar 31, 2023 | -15.30 Mn |
| Dec 31, 2022 | -20.20 Mn |
| Sep 30, 2022 | -23.27 Mn |
| Jun 30, 2022 | -25.47 Mn |
| Mar 31, 2022 | -28.68 Mn |
| Dec 31, 2021 | -30.27 Mn |
| Sep 30, 2021 | -33.79 Mn |